Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pinna

Showing results (131-140 of 595) with videos related to

Pageof 60
Sort By:
Trends in Biochemical Sciences|January 2, 2013
Secreted protein kinasesVincent S Tagliabracci, Lorenzo A Pinna, Jack E Dixon
Trends in Biochemical Sciences|September 3, 2013
Response to Wang et al.: Secreted protein kinases?Vincent S Tagliabracci, Lorenzo A Pinna, Jack E Dixon
Biomed Research International|November 12, 2015
The Selectivity of CK2 Inhibitor Quinalizarin: A ReevaluationGiorgio Cozza, Andrea Venerando, Stefania Sarno, et al.
FEBS Letters|April 13, 1992
The consensus sequences for cdc2 kinase and for casein kinase-2 are mutually incompatible. A study with peptides derived from the beta-subunit of casein kinase-2O Marin, F Meggio, G Draetta, et al.
Oncogene|May 31, 2002
CK2-dependent phosphorylation of the E2 ubiquitin conjugating enzyme UBC3B induces its interaction with beta-TrCP and enhances beta-catenin degradationFrancesca Semplici, Flavio Meggio, Lorenzo A Pinna, et al.
European Journal of Pharmacology|January 4, 1994
Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned ratsM Morelli, S Fenu, A Pinna, et al.
The European Journal of Neuroscience|June 1, 1996
Blockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated ratsA Pinna, G di Chiara, J Wardas, et al.
Archives of Biochemistry and Biophysics|January 1, 1975
Further characterization of mitochondrial protein phosphataseG Clari, A Donella, L A Pinna, et al.
Cell Death Discovery|October 30, 2021
Targeting CK2 in cancer: a valuable strategy or a waste of time?Mauro Salvi, Christian Borgo, Lorenzo A Pinna, et al.
Biochimica Et Biophysica Acta|April 18, 2015
Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarinCinzia Franchin, Mauro Salvi, Giorgio Arrigoni, et al.
Pageof 60

Showing results (131-140 of 595) with videos related to

Sort By:
Pageof 60
Trends in Biochemical Sciences|January 2, 2013
Secreted protein kinasesVincent S Tagliabracci, Lorenzo A Pinna, Jack E Dixon
Trends in Biochemical Sciences|September 3, 2013
Response to Wang et al.: Secreted protein kinases?Vincent S Tagliabracci, Lorenzo A Pinna, Jack E Dixon
Biomed Research International|November 12, 2015
The Selectivity of CK2 Inhibitor Quinalizarin: A ReevaluationGiorgio Cozza, Andrea Venerando, Stefania Sarno, et al.
FEBS Letters|April 13, 1992
The consensus sequences for cdc2 kinase and for casein kinase-2 are mutually incompatible. A study with peptides derived from the beta-subunit of casein kinase-2O Marin, F Meggio, G Draetta, et al.
Oncogene|May 31, 2002
CK2-dependent phosphorylation of the E2 ubiquitin conjugating enzyme UBC3B induces its interaction with beta-TrCP and enhances beta-catenin degradationFrancesca Semplici, Flavio Meggio, Lorenzo A Pinna, et al.
European Journal of Pharmacology|January 4, 1994
Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned ratsM Morelli, S Fenu, A Pinna, et al.
The European Journal of Neuroscience|June 1, 1996
Blockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated ratsA Pinna, G di Chiara, J Wardas, et al.
Archives of Biochemistry and Biophysics|January 1, 1975
Further characterization of mitochondrial protein phosphataseG Clari, A Donella, L A Pinna, et al.
Cell Death Discovery|October 30, 2021
Targeting CK2 in cancer: a valuable strategy or a waste of time?Mauro Salvi, Christian Borgo, Lorenzo A Pinna, et al.
Biochimica Et Biophysica Acta|April 18, 2015
Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarinCinzia Franchin, Mauro Salvi, Giorgio Arrigoni, et al.
Pageof 60